Last reviewed · How we verify
NCT03657615
Hearing Aid Impact on Chronic Tinnitus Patients Evaluated by Resting State PET.
NA trial testing hearing aid fitting in Chronic Tinnitus in 40 participants. Status unknown.
30 September 2018
Quick facts
| Lead sponsor | University of Sao Paulo General Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 15 January 2014 |
| Primary completion | 30 September 2018 |
| Estimated completion | 30 June 2019 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- hearing aid fitting
Conditions studied
- Chronic Tinnitus — all drugs for Chronic Tinnitus →
Sponsor
University of Sao Paulo General Hospital
Who can join
Adults 32 to 62, any sex, with Chronic Tinnitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Using resting state positron emission tomography (PET), our goal was to analyze the metabolic and functional neural changes that occur after 6 months of effective hearing aid (HA) use. Besides, we correlate those changes with behavioral results. Patients with chronic tinnitus and untreated sensorineural hearing loss were tested pre-HA fitting, and at 6 months post-HA fitting.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Hearing aid effectiveness on patients with chronic tinnitus and associated hearing loss.
Simonetti P, Vasconcelos LG, Gândara MR, Lezirovitz K, et al · · 2022 · cited 3× · PMID 35729042 · DOI 10.1016/j.bjorl.2022.03.002
Verify or expand the search:
- PubMed search for NCT03657615
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Tinnitus
Currently open trials in the same condition.
- NCT07393880 — Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal Tinnitus · NA · recruiting
- NCT07155733 — tVNS and Myofascial Release in Tinnitus · NA · active not recruiting
- NCT07183826 — Internet-Based Mindfulness-Based Cognitive Therapy (iMBCT) for Chronic Tinnitus Patients · NA · recruiting
- NCT07185061 — Interventional Treatment of Chronic Tinnitus With Acoustic Stimulation · NA · recruiting
Other University of Sao Paulo General Hospital trials
Trials by the same sponsor.
- NCT07275580 — Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
- NCT07478094 — Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost · not yet recruiting
- NCT07341386 — Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
- NCT07242092 — Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs · Phase 4 · not yet recruiting
- NCT07484152 — Motor and Non-Motor Effects of Low-Intensity Focused Ultrasound (LIFU) as a Neuromodulation Tool in Essential Tremor · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03657615 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Sao Paulo General Hospital
- Last refreshed: 5 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03657615.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing